These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 24178246)
41. Fecal Bacteria Implicated in Biofilm Production Are Enriched and Associate to Gastrointestinal Symptoms in Patients With APECED - A Pilot Study. Hetemäki I; Jian C; Laakso S; Mäkitie O; Pajari AM; de Vos WM; Arstila TP; Salonen A Front Immunol; 2021; 12():668219. PubMed ID: 34367134 [TBL] [Abstract][Full Text] [Related]
45. The altered gut microbiota in adults with cystic fibrosis. Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152 [TBL] [Abstract][Full Text] [Related]
46. [Clinical and radiological findings in the gastrointestinal system in pancreatic insufficiency due to cystic fibrosis]. Pelizza A; Gargani GF; Romano C Radiol Med; 1980 Sep; 66(9):626-9. PubMed ID: 7232794 [No Abstract] [Full Text] [Related]
47. The role of endoscopy and biopsy in the management of severe gastrointestinal disease in cystic fibrosis patients. Shah N; Tan HL; Sebire N; Suri R; Leuven K Pediatr Pulmonol; 2013 Dec; 48(12):1181-9. PubMed ID: 23825099 [TBL] [Abstract][Full Text] [Related]
48. Detection of Shiga toxin-producing and other diarrheagenic Escherichia coli by the BioFire FilmArray® Gastrointestinal Panel in human fecal samples. De Rauw K; Detemmerman L; Breynaert J; Piérard D Eur J Clin Microbiol Infect Dis; 2016 Sep; 35(9):1479-86. PubMed ID: 27259710 [TBL] [Abstract][Full Text] [Related]
52. Decreased Fecal Calprotectin Levels in Cystic Fibrosis Patients After Antibiotic Treatment for Respiratory Exacerbation. Schnapp Z; Hartman C; Livnat G; Shteinberg M; Elenberg Y J Pediatr Gastroenterol Nutr; 2019 Feb; 68(2):282-284. PubMed ID: 30640865 [TBL] [Abstract][Full Text] [Related]
53. Cystic fibrosis in adolescents and young adults. Howie AD; Stack BH Scott Med J; 1979 Jul; 24(3):193-8. PubMed ID: 493947 [TBL] [Abstract][Full Text] [Related]
55. Human extraintestinal pathogenic Escherichia coli strains differ in prevalence of virulence factors, phylogroups, and bacteriocin determinants. Micenková L; Bosák J; Vrba M; Ševčíková A; Šmajs D BMC Microbiol; 2016 Sep; 16():218. PubMed ID: 27646192 [TBL] [Abstract][Full Text] [Related]
56. [Question 2. What strategy for maintaining optimal nutritional state? Influence of nutritional state on the progression of cystic fibrosis: physiopathologic, epidemiologic and clinical aspects of nutrition disorders]. Roullet-Renoleau N Arch Pediatr; 2003 Aug; 10 Suppl 3():449s-452s. PubMed ID: 14671958 [No Abstract] [Full Text] [Related]
57. Associations between micronutrient intakes and gut microbiota in a group of adults with cystic fibrosis. Li L; Krause L; Somerset S Clin Nutr; 2017 Aug; 36(4):1097-1104. PubMed ID: 27595636 [TBL] [Abstract][Full Text] [Related]
58. Role of vitamin D on gut microbiota in cystic fibrosis. Kanhere M; Chassaing B; Gewirtz AT; Tangpricha V J Steroid Biochem Mol Biol; 2018 Jan; 175():82-87. PubMed ID: 27818276 [TBL] [Abstract][Full Text] [Related]
59. Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis. Lisowska A; Madry E; Pogorzelski A; Szydłowski J; Radzikowski A; Walkowiak J Scand J Clin Lab Invest; 2010 Sep; 70(5):322-6. PubMed ID: 20560844 [TBL] [Abstract][Full Text] [Related]
60. An outbreak of Escherichia coli O157 in southern England. Commun Dis Rep CDR Wkly; 1995 Jun; 5(22):103. PubMed ID: 7620521 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]